Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Med Chem ; 65: 448-55, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23748153

RESUMEN

Bisphosphonates (BPs) are key drugs for the treatment of bone resorption diseases like osteoporosis, Paget's disease and some forms of tumors. Recent findings underlined the importance of lipophilic N-containing BPs to ensure high biological activity. Herein we present some unprecedented results concerning the low toxicity and good anti-osteoclast activity of low molecular weight hydrophilic S-containing BPs. A series of S and N-containing BPs bearing aromatic and aliphatic substitution were prepared through Michael addition reaction between vinylidenebisphosphonate tetraethyl ester and the proper nucleophile under basic catalysis. S-containing BPs showed a generally low toxicity, determined with the neutral-red assay using the L929 cell line, and, in particular for an aliphatic one, a good biological activity assessed on primary cultures of human osteoclasts.


Asunto(s)
Difosfonatos/farmacología , Osteoclastos/efectos de los fármacos , Azufre/química , Animales , Apoptosis/efectos de los fármacos , Células Cultivadas , Colágeno/antagonistas & inhibidores , Colágeno/metabolismo , Difosfonatos/síntesis química , Difosfonatos/química , Relación Dosis-Respuesta a Droga , Ratones , Estructura Molecular , Peso Molecular , Osteoclastos/citología , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA